SK282669B6 - Prostriedok na orálne podanie s modifikovaným uvoľňovaním účinnej látky na liečbu zápalových črevných ochorení - Google Patents

Prostriedok na orálne podanie s modifikovaným uvoľňovaním účinnej látky na liečbu zápalových črevných ochorení Download PDF

Info

Publication number
SK282669B6
SK282669B6 SK834-98A SK83498A SK282669B6 SK 282669 B6 SK282669 B6 SK 282669B6 SK 83498 A SK83498 A SK 83498A SK 282669 B6 SK282669 B6 SK 282669B6
Authority
SK
Slovakia
Prior art keywords
granules
aminosalicylic acid
minutes
released
model system
Prior art date
Application number
SK834-98A
Other languages
English (en)
Slovak (sk)
Other versions
SK83498A3 (en
Inventor
Svenn Klver Jepsen
Soren Halskov
Original Assignee
Farmaceutisk Laboratorium Ferring A/S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24302375&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SK282669(B6) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Farmaceutisk Laboratorium Ferring A/S filed Critical Farmaceutisk Laboratorium Ferring A/S
Publication of SK83498A3 publication Critical patent/SK83498A3/sk
Publication of SK282669B6 publication Critical patent/SK282669B6/sk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/606—Salicylic acid; Derivatives thereof having amino groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Transplantation (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SK834-98A 1995-12-21 1996-12-23 Prostriedok na orálne podanie s modifikovaným uvoľňovaním účinnej látky na liečbu zápalových črevných ochorení SK282669B6 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US57595495A 1995-12-21 1995-12-21
PCT/DK1996/000551 WO1997023199A1 (en) 1995-12-21 1996-12-23 Modified release oral pharmaceutical composition containing 5-asa and method for the treatment of bowel diseases

Publications (2)

Publication Number Publication Date
SK83498A3 SK83498A3 (en) 1999-01-11
SK282669B6 true SK282669B6 (sk) 2002-11-06

Family

ID=24302375

Family Applications (1)

Application Number Title Priority Date Filing Date
SK834-98A SK282669B6 (sk) 1995-12-21 1996-12-23 Prostriedok na orálne podanie s modifikovaným uvoľňovaním účinnej látky na liečbu zápalových črevných ochorení

Country Status (28)

Country Link
EP (1) EP0871434B2 (zh)
JP (1) JP4714836B2 (zh)
KR (2) KR100542544B1 (zh)
CN (1) CN1155369C (zh)
AT (1) ATE205704T1 (zh)
AU (1) AU702934B2 (zh)
BG (1) BG63484B1 (zh)
BR (1) BR9612213A (zh)
CA (1) CA2240281C (zh)
CZ (1) CZ289290B6 (zh)
DE (2) DE69615400T3 (zh)
DK (1) DK0871434T4 (zh)
EE (1) EE03740B1 (zh)
ES (1) ES2149733T5 (zh)
HK (1) HK1017615A1 (zh)
HU (1) HU228856B1 (zh)
IL (1) IL124858A (zh)
IS (1) IS1834B (zh)
NO (1) NO320498B1 (zh)
NZ (1) NZ325201A (zh)
PL (1) PL186790B1 (zh)
PT (1) PT871434E (zh)
RU (1) RU2181043C2 (zh)
SI (1) SI0871434T2 (zh)
SK (1) SK282669B6 (zh)
TR (1) TR199801158T2 (zh)
UA (1) UA67721C2 (zh)
WO (1) WO1997023199A1 (zh)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19732903A1 (de) 1997-07-30 1999-02-04 Falk Pharma Gmbh Pellet-Formulierung zur Behandlung des Intestinaltraktes
NZ513037A (en) 1999-01-29 2003-05-30 Disphar Internat B Coated sustained release pharmaceutical composition for the release of an agent in the gastrointestinal tract
CA2359812C (en) 2000-11-20 2004-02-10 The Procter & Gamble Company Pharmaceutical dosage form with multiple coatings for reduced impact of coating fractures
KR100859358B1 (ko) * 2001-10-15 2008-09-22 훼링 비.브이. 궤양성 대장염 및 크론병의 치료에 유용한5-아미노살리실산을 포함하는 약학적 조성물의 제조 방법
US8282955B2 (en) 2001-10-15 2012-10-09 Ferring B.V. Method for the preparation of a pharmaceutical composition comprising 5-aminosalicylic acid for use in treatment of ulcerative colitis and Crohn's disease
US20070042143A1 (en) * 2003-04-23 2007-02-22 Ferring B.V. Sachet for a pharmaceutical composition
EP1547601A1 (en) * 2003-12-23 2005-06-29 Ferring B.V. Coating method
RU2297835C1 (ru) 2005-09-26 2007-04-27 Закрытое акционерное общество "Партнер" Препарат для лечения неинфекционных воспалительных болезней кишечника
US8455470B2 (en) * 2006-04-13 2013-06-04 Neurotech Pharmaceuticals Co., Ltd Pharmaceutical composition for treating or preventing degenerative and inflammatory diseases
US8569375B2 (en) * 2008-08-22 2013-10-29 Reckitt Benckiser Healthcare (Uk) Limited Compositions
EP2334178A4 (en) 2008-10-03 2012-04-11 Falk Pharma Gmbh COMPOSITIONS AND METHODS OF TREATING THERAPEUTIC DISEASES WITH GRANULATED MESALAMINE
EP2340812A1 (en) 2009-12-18 2011-07-06 Ferring International Center S.A. Granules for pharmaceutical preparations, methods and apparatus for their production
RU2463055C2 (ru) * 2011-01-12 2012-10-10 Петр Леонидович Щербаков Способ лечения воспалительных заболеваний кишечника
CN102319218B (zh) * 2011-09-22 2014-10-01 贝沃特医药技术(上海)有限公司 一种治疗肠道疾病的药物缓控释微粒制剂及其制备方法
WO2013144176A1 (en) 2012-03-30 2013-10-03 Laboratorios Del Dr. Esteve, S.A. Controlled release formulatin comprising mesalamine
RU2752082C1 (ru) * 2020-09-29 2021-07-22 федеральное государственное бюджетное образовательное учреждение высшего образования "Башкирский государственный медицинский университет" Министерства здравоохранения Российской Федерации Средство с гранулами, содержащими 5-аминосалициловую кислоту и фолиевую кислоту, с контролируемым высвобождением

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1981002671A1 (en) * 1980-03-20 1981-10-01 Ferring Farma Lab Pharmaceutical composition and method for the treatment of colitis ulcerosa and crohn's disease by oral administration
SE457505B (sv) * 1984-01-10 1989-01-09 Lejus Medical Ab Laminatbelagd oral farmaceutisk komposition och foerfarande foer dess framstaellning
GB8926639D0 (en) * 1989-11-24 1990-01-17 Agricultural & Food Res Delayed release formulations
IT1246382B (it) * 1990-04-17 1994-11-18 Eurand Int Metodo per la cessione mirata e controllata di farmaci nell'intestino e particolarmente nel colon

Also Published As

Publication number Publication date
HUP0001084A2 (hu) 2000-11-28
CZ194698A3 (cs) 1998-10-14
IS1834B (is) 2002-11-15
PL186790B1 (pl) 2004-02-27
SI0871434T1 (en) 2002-04-30
DK0871434T3 (da) 2002-01-07
ES2149733T5 (es) 2008-05-01
CA2240281A1 (en) 1997-07-03
ATE205704T1 (de) 2001-10-15
ES2149733T3 (es) 2002-04-01
EP0871434A1 (en) 1998-10-21
DE69615400D1 (de) 2001-10-25
BR9612213A (pt) 1999-12-28
AU702934B2 (en) 1999-03-11
UA67721C2 (en) 2004-07-15
NZ325201A (en) 1998-11-25
CN1155369C (zh) 2004-06-30
HUP0001084A3 (en) 2000-12-28
AU1366197A (en) 1997-07-17
SI0871434T2 (sl) 2008-04-30
JPH11510191A (ja) 1999-09-07
BG63484B1 (bg) 2002-03-29
PT871434E (pt) 2002-02-28
IL124858A0 (en) 1999-01-26
SK83498A3 (en) 1999-01-11
NO982904L (no) 1998-06-22
WO1997023199A1 (en) 1997-07-03
EE9800191A (et) 1998-12-15
HK1017615A1 (en) 1999-11-26
IS4772A (is) 1998-06-15
ES2149733T1 (es) 2000-11-16
IL124858A (en) 2003-03-12
NO320498B1 (no) 2005-12-12
KR100542544B1 (ko) 2006-05-10
TR199801158T2 (xx) 1998-09-21
HU228856B1 (en) 2013-06-28
DE69615400T2 (de) 2002-05-23
PL327323A1 (en) 1998-12-07
EE03740B1 (et) 2002-06-17
KR100598714B1 (ko) 2006-07-10
KR19990076584A (ko) 1999-10-15
EP0871434B1 (en) 2001-09-19
KR20050087886A (ko) 2005-08-31
CN1207672A (zh) 1999-02-10
DK0871434T4 (da) 2008-04-07
EP0871434B2 (en) 2007-12-12
BG102556A (en) 1999-02-26
CZ289290B6 (cs) 2001-12-12
NO982904D0 (no) 1998-06-22
RU2181043C2 (ru) 2002-04-10
CA2240281C (en) 2007-02-27
JP4714836B2 (ja) 2011-06-29
DE871434T1 (de) 2001-04-05
DE69615400T3 (de) 2008-08-07

Similar Documents

Publication Publication Date Title
EP1562573B1 (en) Pharmaceutical pellets comprising tamsulosin and a process for making the same
JP4789806B2 (ja) パントプラゾール多粒子処方
SK282669B6 (sk) Prostriedok na orálne podanie s modifikovaným uvoľňovaním účinnej látky na liečbu zápalových črevných ochorení
NZ204856A (en) Analgesic capsules containing aspirin and p-acetylaminophenol
US6004581A (en) Modified release oral pharmaceutical composition and method for the treatment of bowel diseases
EP1128826B1 (en) Chromone enteric release formulation
JP2012511039A (ja) 固定用量組合せのためのタムスロシンペレット剤
WO2010036975A2 (en) Dipyridamole and acetylsalicylic acid formulations and process for preparing same
EP4213817A1 (en) Multi-particulate pharmaceutical composition of quetiapine
GB2324962A (en) Chromone compositions for bio-availability to the small intestine
CZ20003137A3 (cs) Farmaceutický preparát s topiramátem
AU2006236052A1 (en) Oral pulsed dose drug delivery system

Legal Events

Date Code Title Description
MK4A Patent expired

Expiry date: 20161223